SARS-CoV-2 Rapid Antigen Nasal Test at HuntOffice™
Channel: HuntOffice
Date: 19/04/2021

Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens.
In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples.
For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected.
Overall, the studies contained 468 symptomatic and asymptomatic individuals.
This test is intended to detect antigen from SARS‑CoV‑2 in individuals suspected of COVID‑19 or with known or suspected exposure to SARS‑CoV‑2.
Intended for Professional use in Laboratory and Point of Care Environments, and/or self-collection under the close supervision of a healthcare worker.
Kit Contents:
Test Device (individually in a foil pouch with desiccant)
Extraction buffer tube and buffer tube rack
Nozzle cap
Sterile swab
Quick Reference Guide
Instructions for use
Positive and negative controls
Pack of 25
Limitations of COVID-19 antigen testing
No test is 100% accurate. All tests have limitations.
The antigen test is less accurate than the COVID-19 PCR test.
The test will find the virus in most people who have symptoms.
But in some cases, it may not pick up that you have the virus.
If you have COVID-19 symptoms, tell a healthcare worker immediately.

For Price & More Visit : https://www.huntoffice.ie/sars-cov-2-antigen-rapid-nasal-test-kit-single-pack.html

Video Credit From Supplier: Primary Care Supplies